PDS Biotechnology (PDSB) said Thursday it is selling about 7.3 million common shares and warrants to purchase up to about 7.3 million common shares in a registered direct offering at a combined purchase price of $1.50 for institutional investors and $1.66 for certain PDS Biotechnology directors.
The company said about $11 million will be fully funded upon the closing of the offering, which is expected to occur on or about Friday, and up to $11 million more may be funded upon full cash exercise of the warrants, which have an exercise price of $1.50 per share, according to the company.
Net proceeds from the offering are expected to be used for research and development expenses and general corporate purposes, the company said.
Shares of PDS Biotechnology were up 4.6% in recent Thursday trading.
Price: 1.61, Change: +0.07, Percent Change: +4.55
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。